Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine

Affiliations

Peter Lee et al. N Engl J Med. 2023.

. 2023 Mar 30;388(13):1233-1239.

doi: 10.1056/NEJMsr2214184.

¹ From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.).

No abstract available

Comment in

Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine.
Kataoka Y, So R. Kataoka Y, et al. N Engl J Med. 2023 Jun 22;388(25):2399. doi: 10.1056/NEJMc2305286. N Engl J Med. 2023. PMID: 37342939 No abstract available.
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine.
Fernandes AC, Souto MEVC. Fernandes AC, et al. N Engl J Med. 2023 Jun 22;388(25):2399-2400. doi: 10.1056/NEJMc2305286. N Engl J Med. 2023. PMID: 37342940 No abstract available.
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. Reply.
Lee P, Bubeck S, Petro J. Lee P, et al. N Engl J Med. 2023 Jun 22;388(25):2400. doi: 10.1056/NEJMc2305286. N Engl J Med. 2023. PMID: 37342941 No abstract available.